| Cohort group |  | ||
---|---|---|---|---|
Characteristic | HIV− | HIV+ (no HIVE) | HIV + HIVE | p value HIV+ vs. HIVE |
Number of subjects | 112 | 350 | 92 | – |
Age at death, mean ± SD | 54.5 ± 16.8 | 42.8 ± 10.1 | 41.1 ± 7.7 | 0.11a |
Hours postmortem, mean ± SD | 15.2 ± 10.9 | 14.3 ± 13.3 | 15.5 ± 18.9 | 0.247a |
Sex | ||||
 Male (%) | 67 (60%) | 296 (85%) | 85 (92%) | 0.21b |
Race | ||||
 Caucasian (%) | 84 (76%) | 209 (60%) | 53 (58%) | 0.88b |
 African American (%) | 24 (22%) | 116 (33%) | 33 (36%) | |
 Other/Unknown (%) | 3 (2.7%) | 25 (7.1%) | 6 (6.5%) | |
Ethnicity | ||||
 Hispanic (%) | 22 (20%) | 65 (19%) | 22 (24%) | 0.25b |
Disease parameters | ||||
 Log plasma HIV copies/mL, mean ± SD | – | 4.1 ± 1.3 | 5.1 ± 0.9 | < 0.001a |
 Log CSF HIV copies/mL, mean ± SD | – | 2.8 ± 1.0 | 4.3 ± 1.6 | < 0.001a |
 Log brain HIV copies/g, mean ± SD | – | 3.6 ± 1.2 | 5.9 ± 1.9 | < 0.001a |
 CD4+ lymphocytes/mm3, mean ± SD | – | 111 ± 168 | 45 ± 58 | 0.003a |